You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 59 No. 6, June 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on ISI (39)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •HIV/AIDS
 •Immunologic Disorders
 •Alert me on articles by topic

Progression to Neuropsychological Impairment in Human Immunodeficiency Virus Infection Predicted by Elevated Cerebrospinal Fluid Levels of Human Immunodeficiency Virus RNA

Ronald J. Ellis, MD, PhD; David J. Moore, BS; Meredith E. Childers, MA; Scott Letendre, MD; J. Allen McCutchan, MD; Tanya Wolfson, MA; Stephen A. Spector, MD; Karen Hsia, PhD; Robert K. Heaton, PhD; Igor Grant, MD; for the HNRC Group

Arch Neurol. 2002;59:923-928.

Background  If cerebrospinal fluid (CSF) human immunodeficiency virus (HIV) RNA levels are elevated before the development of neuropsychological (NP) impairment, such an observation would support prospective monitoring of CSF HIV RNA levels as well as therapeutic interventions designed to lower CSF HIV levels.

Objective  To determine whether increased CSF HIV RNA levels at an earlier time predict subsequent progression to NP impairment in HIV-infected subjects.

Methods  We examined 139 subjects in a prospective cohort study. Comprehensive NP, neuromedical, and laboratory evaluations were performed at initial and follow-up visits at least 6 months apart. Human immunodeficiency virus RNA levels in plasma and CSF were measured with a commercially available, polymerase chain reaction–based assay. To assess the robustness of our findings, we analyzed changes in NP performance over time in 2 ways. First, we used masked clinical ratings of global NP performance to identify individuals who were initially NP normal, and then determined, in a similarly blinded fashion, which of these subjects subsequently became NP impaired. Second, in a separate analysis, we assessed change in subjects' raw scores on each of a series of NP test measures between baseline and follow-up.

Results  Among subjects who were not impaired at the initial visit, higher levels of HIV RNA in CSF significantly predicted progression to global NP impairment at the follow-up evaluation. Cerebrospinal fluid HIV RNA levels outperformed other clinical and laboratory measures in predicting progression to NP impairment. Higher CSF HIV RNA levels were associated with worsening performance on tests of attention, learning, and motor function.

Conclusion  Because elevated CSF HIV RNA levels (>=200 copies/mL) predict subsequent progression to NP impairment, monitoring of CSF viral load and therapy to reduce CSF HIV RNA levels may be clinically warranted, even if impairment is not identified at the time of lumbar puncture.


From the Department of Neurosciences (Dr Ellis and Ms Childers), HIV Neurobehavioral Research Center (HNRC) (Drs Ellis, Letendre, McCutchan, Heaton, and Grant, Mr Moore, and Mss Childers and Wolfson), and Departments of Psychiatry (Mr Moore and Drs Heaton and Grant), Medicine (Drs Letendre and McCutchan), and Pediatrics (Drs Spector and Hsia), University of California, San Diego (UCSD); San Diego State University/UCSD Joint Doctoral Program in Clinical Psychology (Mr Moore); and Veterans Affairs Healthcare System (Dr Grant), San Diego. The San Diego HNRC Group is affiliated with the University of California, San Diego, the Naval Hospital, San Diego, and the San Diego Veterans Affairs Healthcare System.


RELATED ARTICLES

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2002;59(6):1048-1050.
FULL TEXT  

Through a Glass, Darkly: Cerebrospinal Fluid Viral Load Measurements and the Pathogenesis of Human Immunodeficiency Virus Infection of the Central Nervous System
Kenneth L. Tyler and Justin C. McArthur
Arch Neurol. 2002;59(6):909-912.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.